Suppr超能文献

为精确测量细胞中的蛋白质相互作用而优化的纳米荧光素互补报告基因。

NanoLuc Complementation Reporter Optimized for Accurate Measurement of Protein Interactions in Cells.

作者信息

Dixon Andrew S, Schwinn Marie K, Hall Mary P, Zimmerman Kris, Otto Paul, Lubben Thomas H, Butler Braeden L, Binkowski Brock F, Machleidt Thomas, Kirkland Thomas A, Wood Monika G, Eggers Christopher T, Encell Lance P, Wood Keith V

机构信息

Promega Corporation , Madison, Wisconsin 53711, United States.

Promega Biosciences Incorporated , San Luis Obispo, California 93401, United States.

出版信息

ACS Chem Biol. 2016 Feb 19;11(2):400-8. doi: 10.1021/acschembio.5b00753. Epub 2015 Dec 10.

Abstract

Protein-fragment complementation assays (PCAs) are widely used for investigating protein interactions. However, the fragments used are structurally compromised and have not been optimized nor thoroughly characterized for accurately assessing these interactions. We took advantage of the small size and bright luminescence of NanoLuc to engineer a new complementation reporter (NanoBiT). By design, the NanoBiT subunits (i.e., 1.3 kDa peptide, 18 kDa polypeptide) weakly associate so that their assembly into a luminescent complex is dictated by the interaction characteristics of the target proteins onto which they are appended. To ascertain their general suitability for measuring interaction affinities and kinetics, we determined that their intrinsic affinity (KD = 190 μM) and association constants (kon = 500 M(-1) s(-1), koff = 0.2 s(-1)) are outside of the ranges typical for protein interactions. The accuracy of NanoBiT was verified under defined biochemical conditions using the previously characterized interaction between SME-1 β-lactamase and a set of inhibitor binding proteins. In cells, NanoBiT fusions to FRB/FKBP produced luminescence consistent with the linear characteristics of NanoLuc. Response dynamics, evaluated using both protein kinase A and β-arrestin-2, were rapid, reversible, and robust to temperature (21-37 °C). Finally, NanoBiT provided a means to measure pharmacology of kinase inhibitors known to induce the interaction between BRAF and CRAF. Our results demonstrate that the intrinsic properties of NanoBiT allow accurate representation of protein interactions and that the reporter responds reliably and dynamically in cells.

摘要

蛋白质片段互补分析(PCA)被广泛用于研究蛋白质相互作用。然而,所使用的片段在结构上存在缺陷,尚未针对准确评估这些相互作用进行优化或全面表征。我们利用NanoLuc的小尺寸和明亮发光特性设计了一种新的互补报告基因(NanoBiT)。通过设计,NanoBiT亚基(即1.3 kDa肽、18 kDa多肽)之间的结合较弱,因此它们组装成发光复合物取决于与其融合的靶蛋白的相互作用特性。为了确定它们在测量相互作用亲和力和动力学方面的总体适用性,我们测定了它们的内在亲和力(KD = 190 μM)和缔合常数(kon = 500 M-1 s-1,koff = 0.2 s-1),这些值超出了蛋白质相互作用的典型范围。在确定的生化条件下,利用先前表征的SME-1β-内酰胺酶与一组抑制剂结合蛋白之间的相互作用,验证了NanoBiT的准确性。在细胞中,与FRB/FKBP融合的NanoBiT产生的发光与NanoLuc的线性特征一致。使用蛋白激酶A和β-抑制蛋白2评估的反应动力学快速、可逆,并且在21-37°C的温度范围内稳定。最后,NanoBiT提供了一种测量已知可诱导BRAF和CRAF相互作用的激酶抑制剂药理学的方法。我们的结果表明,NanoBiT的内在特性能够准确反映蛋白质相互作用,并且该报告基因在细胞中能够可靠且动态地响应。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验